KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Inventory (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Inventory for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Inventory rose 2.13% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 2.13% year-over-year, with the annual reading at $1.6 billion for FY2025, 2.13% up from the prior year.
  • Inventory hit $1.6 billion in Q4 2025 for Bausch Health Companies, up from $1.6 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.7 billion in Q3 2024 to a low of $993.0 million in Q4 2021.
  • Historically, Inventory has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2023.
  • Biggest five-year swings in Inventory: decreased 13.56% in 2021 and later skyrocketed 41.65% in 2023.
  • Year by year, Inventory stood at $993.0 million in 2021, then rose by 9.77% to $1.1 billion in 2022, then surged by 41.65% to $1.5 billion in 2023, then increased by 3.3% to $1.6 billion in 2024, then grew by 2.13% to $1.6 billion in 2025.
  • Business Quant data shows Inventory for BHC at $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.7 billion in Q2 2025.